Follow
Amy Sherborne
Amy Sherborne
Verified email at icr.ac.uk
Title
Cited by
Cited by
Year
Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas
C Palles, JB Cazier, KM Howarth, E Domingo, AM Jones, P Broderick, ...
Nature genetics 45 (2), 136-144, 2013
10712013
Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk
AL Sherborne, FJ Hosking, RB Prasad, R Kumar, R Koehler, ...
Nature genetics 42 (6), 492-494, 2010
3102010
Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients
V Shah, AL Sherborne, BA Walker, DC Johnson, EM Boyle, S Ellis, ...
Leukemia 32 (1), 102-110, 2018
2282018
The genetic basis of inbreeding avoidance in house mice
AL Sherborne, MD Thom, S Paterson, F Jury, WER Ollier, P Stockley, ...
Current biology 17 (23), 2061-2066, 2007
2152007
Variation at 10p12. 2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotype
G Migliorini, B Fiege, FJ Hosking, Y Ma, R Kumar, AL Sherborne, ...
Blood, the Journal of the American Society of Hematology 122 (19), 3298-3307, 2013
1682013
Rare disruptive mutations and their contribution to the heritable risk of colorectal cancer
D Chubb, P Broderick, SE Dobbins, M Frampton, B Kinnersley, S Penegar, ...
Nature communications 7 (1), 11883, 2016
1512016
Genetic diagnosis of high-penetrance susceptibility for colorectal cancer (CRC) is achievable for a high proportion of familial CRC by exome sequencing
D Chubb, P Broderick, M Frampton, B Kinnersley, A Sherborne, ...
Journal of Clinical Oncology 33 (5), 426-432, 2015
992015
Baculum morphology predicts reproductive success of male house mice under sexual selection
P Stockley, SA Ramm, AL Sherborne, MDF Thom, S Paterson, JL Hurst
BMC biology 11, 1-6, 2013
862013
Clonal evolution in myeloma: the impact of maintenance lenalidomide and depth of response on the genetics and sub-clonal structure of relapsed disease in uniformly treated …
JR Jones, N Weinhold, C Ashby, BA Walker, C Wardell, C Pawlyn, ...
Haematologica 104 (7), 1440, 2019
822019
Developmental timing of mutations revealed by whole-genome sequencing of twins with acute lymphoblastic leukemia
Y Ma, SE Dobbins, AL Sherborne, D Chubb, M Galbiati, G Cazzaniga, ...
Proceedings of the National Academy of Sciences 110 (18), 7429-7433, 2013
742013
The silent mutational landscape of infant MLL‐AF4 pro‐B acute lymphoblastic leukemia
SE Dobbins, AL Sherborne, YP Ma, M Bardini, A Biondi, G Cazzaniga, ...
Genes, Chromosomes and Cancer 52 (10), 954-960, 2013
692013
Role of 657del5 NBN mutation and 7p12. 2 (IKZF1), 9p21 (CDKN2A), 10q21. 2 (ARID5B) and 14q11. 2 (CEBPE) variation and risk of childhood ALL in the Polish population
A Pastorczak, P Górniak, A Sherborne, F Hosking, J Trelińska, M Lejman, ...
Leukemia research 35 (11), 1534-1536, 2011
692011
Variation at 7p12. 2 and 10q21. 2 influences childhood acute lymphoblastic leukemia risk in the Thai population and may contribute to racial differences in leukemia incidence
J Vijayakrishnan, AL Sherborne, R Sawangpanich, S Hongeng, ...
Leukemia & lymphoma 51 (10), 1870-1874, 2010
552010
Rationale for an international consortium to study inherited genetic susceptibility to childhood acute lymphoblastic leukemia
AL Sherborne, K Hemminki, R Kumar, CR Bartram, M Stanulla, ...
Haematologica 96 (7), 1049, 2011
532011
Multiple Hodgkin lymphoma–associated loci within the HLA region at chromosome 6p21. 3
L Moutsianas, V Enciso-Mora, YP Ma, S Leslie, A Dilthey, P Broderick, ...
Blood, The Journal of the American Society of Hematology 118 (3), 670-674, 2011
502011
Subclonal TP53 copy number is associated with prognosis in multiple myeloma
V Shah, DC Johnson, AL Sherborne, S Ellis, FM Aldridge, ...
Blood, The Journal of the American Society of Hematology 132 (23), 2465-2469, 2018
402018
Mutational analysis of ionizing radiation induced neoplasms
AL Sherborne, PR Davidson, K Yu, AO Nakamura, M Rashid, ...
Cell reports 12 (11), 1915-1926, 2015
392015
Somatic and Germline TP53 Alterations in Second Malignant Neoplasms from Pediatric Cancer Survivors
AL Sherborne, V Lavergne, K Yu, L Lee, PR Davidson, T Mazor, ...
Clinical Cancer Research 23 (7), 1852-1861, 2017
352017
Predicting ultrahigh risk multiple myeloma by molecular profiling: an analysis of newly diagnosed transplant eligible myeloma XI trial patients
V Shah, AL Sherborne, DC Johnson, S Ellis, A Price, F Chowdhury, ...
Leukemia 34 (11), 3091-3096, 2020
342020
Copy number evolution and its relationship with patient outcome—an analysis of 178 matched presentation-relapse tumor pairs from the Myeloma XI trial
J Croft, S Ellis, AL Sherborne, K Sharp, A Price, MW Jenner, MT Drayson, ...
Leukemia 35 (7), 2043-2053, 2021
282021
The system can't perform the operation now. Try again later.
Articles 1–20